Drug · DIN 02236876
ALPHAGAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 27, 2024; first marketed December 2, 1997.
- Drug Identification Number (DIN)
- 02236876
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Brimonidine S01EA05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BRIMONIDINE TARTRATE | 0.2 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 29, 2022: NOC 29133New Drug Submission (NDS) · Administrative: Merger/Buy-out
- November 24, 1997: NOC 3315New Drug Submission (NDS)